Levogastrol Tablet contains Levosulpiride 25 mg, a selective dopamine D2 receptor antagonist primarily utilized for its prokinetic and antipsychotic properties. It is indicated for the treatment of gastrointestinal motility disorders such as functional dyspepsia, gastroesophageal reflux disease (GERD), and diabetic gastroparesis, where it enhances gastric emptying and alleviates symptoms like nausea, vomiting, bloating, and abdominal discomfort. Additionally, Levosulpiride exhibits central nervous system effects beneficial in managing psychiatric conditions including schizophrenia and depression, owing to its modulation of dopaminergic pathways. The drug acts by blocking dopamine receptors in the gastrointestinal tract and central nervous system, thereby improving motility and exerting mood-stabilizing effects. Levogastrol is generally well tolerated; however, adverse effects may include extrapyramidal symptoms, hyperprolactinemia, sedation, and gastrointestinal disturbances. It is contraindicated in patients with hypersensitivity to sulpiride, prolactin-dependent tumors, and severe renal or hepatic impairment. Caution is advised when co-administered with other dopamine antagonists or CNS depressants. Dosage should be individualized based on the clinical condition and patient response. Levogastrol Tablet should be used under medical supervision to optimize therapeutic outcomes and minimize potential risks.